Literature DB >> 31061114

QnAs with Alexander Levitzki.

Sandeep Ravindran.   

Abstract

Year:  2019        PMID： 31061114      PMCID： PMC6575594          DOI： 10.1073/pnas.1906350116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  3 in total

1.  My journey from tyrosine phosphorylation inhibitors to targeted immune therapy as strategies to combat cancer.

Authors:  Alexander Levitzki; Shoshana Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-10       Impact factor: 11.205

2.  Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors.

Authors:  P Yaish; A Gazit; C Gilon; A Levitzki
Journal:  Science       Date:  1988-11-11       Impact factor: 47.728

3.  Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling.

Authors:  E Sanchez-Lopez; E Flashner-Abramson; S Shalapour; Z Zhong; K Taniguchi; A Levitzki; M Karin
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.